Baloxavir marboxil in Japanese patients with seasonal influenza: Dose response and virus type/subtype outcomes from a randomized phase 2 study
- 1 March 2019
- journal article
- research article
- Published by Elsevier in Antiviral Research
- Vol. 163, 75-81
Abstract
No abstract availableKeywords
Funding Information
- Shionogi & Co., Ltd
This publication has 4 references indexed in Scilit:
- In vitro characterization of baloxavir acid, a first-in-class cap-dependent endonuclease inhibitor of the influenza virus polymerase PA subunitAntiviral Research, 2018
- Safety, Tolerability, and Pharmacokinetics of the Novel Anti-influenza Agent Baloxavir Marboxil in Healthy Adults: Phase I Study FindingsClinical Drug Investigation, 2018
- Baloxavir Marboxil for Uncomplicated Influenza in Adults and AdolescentsNew England Journal of Medicine, 2018
- Neuraminidase inhibitors for influenza B virus infection: Efficacy and resistanceAntiviral Research, 2013